Evaluation of the combination of a biofilm-disrupting agent and negative pressure wound therapy: a case series
Authors:
- 2 January 2021
- journal article
- research article
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 30 (1) , 9-14
Abstract
Objective: Approximately three million people in the US have hard-to-heal pressure ulcers (PUs), including 10% of hospitalised patients. Healing depends on ulcer stage and patient comorbidities. Despite advances in nutrition and wound care, PUs can take months or years to reach complete closure. To date, clinical studies have focused on single modality therapy. However, there is no one therapy that can address all of the deficits in these complex, hard-to-heal wounds. A commonly used treatment for PUs, negative pressure wound therapy (NPWT), has demonstrated improved healing in Stage 3 and 4 PUs. NPWT entails applying suction to a porous sponge fitted into the wound cavity and sealed with an occlusive dressing. Negative pressure facilitates wound healing by removing wound fluid containing harmful proteases, stimulating the formation of granulation tissue and promoting wound contracture. However, it does not affect biofilm formation. We hypothesised that adding an antibiofilm agent might increase the effectiveness of NPWT in recalcitrant PUs. Method: A prospective case series was conducted in outpatient wound care centres and a skilled nursing facility to examine the combination of a biofilm-disrupting antimicrobial agent (Blast-X, Next Science, US) in combination with NPWT (VAC, 3M, US) in healing and reducing bacterial burden in treatment-resistant pressure ulcers. Patients consented to application of the antibiofilm agent and NPWT three times per week for four weeks. The wounds were measured, imaged for bacteria and tested for host and bacterial protease activity weekly. Results: Of the 10 patients, four dropped out of the study before the end of the four weeks. Of the remaining six, four patients experienced a reduction in wound surface area and volume, reduced protease activity and lower bacterial levels. Conclusion: The results of this study showed that multimodal therapy, including NPWT and biofilm disruption, may restart the healing of stagnant treatment-resistant PUs.Keywords
This publication has 16 references indexed in Scilit:
- Defining a new diagnostic assessment parameter for wound care: Elevated protease activity, an indicator of nonhealing, for targeted protease‐modulating treatmentWound Repair and Regeneration, 2016
- Disrupting the biofilm matrix improves wound healing outcomesJournal of Wound Care, 2015
- Treatment of Pressure Ulcers: A Clinical Practice Guideline From the American College of PhysiciansAnnals of Internal Medicine, 2015
- The Effect of Vacuum-Assisted Closure on the Bacterial Load and Type of Bacteria: A Systematic ReviewAdvances in Wound Care, 2014
- A self-completed nutrition screening tool for community-dwelling older adults with high reliability: A comparison studyThe Journal of nutrition, health and aging, 2013
- Negative Pressure Wound Therapy With Instillation (NPWTi) Better Reduces Post-debridement Bioburden in Chronically Infected Lower Extremity Wounds Than NPWT AloneJournal of the American College of Clinical Wound Specialists, 2012
- Optimal use of negative pressure wound therapy in treating pressure ulcersInternational Wound Journal, 2012
- Clinically Addressing Biofilm in Chronic WoundsAdvances in Wound Care, 2012
- The mechanisms of action of vacuum assisted closure: More to learnSurgery, 2009
- Physiology of the Chronic WoundClinics in Plastic Surgery, 1998